is semaglutide under patent With semaglutide's expiring, generics are set to enter from soon, setting off competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs- are Ozempic's Patent Protection Starts to

This 6 kDa peptide hormone, naturally upregulated during childbirth to soften the cervix, has been studied for adhesive capsulitis (frozen shoulder) because it directly targets fibrosis, the underlying cause of the condition

In a 2022 study of 175 overweight and obese patients (some with type 2 diabetes and some without), the study participants lost an average of 5.9% of their body weight after using Wegovy for three months and an average of 10.9% of their body weight after six months of treatment

By Week 72, 88% of participants received and maintained the full target dose of semaglutide 2.4 mg

After coronary artery ligation in mice, intraperitoneal T4 treatment upregulated cardiac ILK and Akt activity, enhanced early myocyte survival, and improved cardiac function establishing the mechanistic basis for the broader tissue-repair claims associated with thymosin beta-4 and its 1723 fragment TB-500

R.KennedyC